Login

Mr. CEO Unveils Embraer's New Turboprop with 250+ LOIs | Arjan Meijer - CEO of Embraer 00:10:00

Share On Facebook Share On Twitter

Arjan Meijer is Pres/CEO:Commercial Aviation at Embraer SA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Capital Solutions at Apollo: A Vision for Integrated Growth | Craig Farr - Apollo Global Management
00:10:00
Paul Beste, COO at Heartland Advisors, Highlights the Successful Collaboration with Todd Noteboom and Leonard, Street and Deinard
00:10:00
Powering Progress: Nomination for the EY Green Transition Award 2023 | Jörg Brinkmann, Chief Executive Officer of H+H International
00:10:00
Aequitas NEO Exchange Inc, a new Canadian stock exchange, is described by President and CEO Jos Schmitt, highlighting its unique features and approach to capital markets.|Warner Arms Henderson, ChFC® is Founder and Principal of
00:10:00
John Proust Discusses Japan Gold's Alliance with Barrick and Exploration Potential in Japan
00:10:00
UiPath founders and Co-CEOs Rob Enslin and Daniel Dines discuss their company with theCUBE's Dave Vellante and David Nicholson at UiPath.
00:10:00
West High Yield Resources' Magnesium Mine: Strategic Importance and Environmental Considerations
00:10:00
Tommy Discusses Burkina Faso Exploration Plans Ahead of ASX Listing
00:10:00
Skyharbour CEO Discusses High-Grade Uranium Projects at 1-2-1 Mining Conference in New York
00:10:00
David Hult on Car Market Trends and Valuation Expectations | David Hult, CEO, Asbury Automotive Group.
00:10:00
Milan Patel, CEO of Dotdigital, highlights the significant growth driven by new and existing customers, with SMS channels playing a crucial role​|Milan Patel, CEO of Dotdigital
00:10:00
Black Swan” ideas with significant upside or a significantly better mousetrap|Samir Kaul,Founding General Partner,Khosla Ventures

© 2017 - Neuhu+